Quest Diagnostics
DGX
#1036
Rank
โ‚น1.577 T
Marketcap
โ‚น14,218
Share price
-0.37%
Change (1 day)
30.13%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2023 (TTM): โ‚น557.67

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น578.99. In 2022 the company made an earnings per share (EPS) of โ‚น690.34 a decrease over its 2021 EPS that were of โ‚น1,359.

EPS history for Quest Diagnostics from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)โ‚น557.67-19.22%
2022โ‚น690.34-49.21%
2021โ‚น1,35949.72%
2020โ‚น907.8966.67%
2019โ‚น544.7318%
2018โ‚น461.65-4.26%
2017โ‚น482.2123.19%
2016โ‚น391.42-7.11%
2015โ‚น421.4028.46%
2014โ‚น328.04-31.61%
2013โ‚น479.6460.46%
2012โ‚น298.92-16.51%
2011โ‚น358.022.45%
2010โ‚น349.454.35%
2009โ‚น334.8930.77%
2008โ‚น256.0968.93%
2007โ‚น151.60-40.6%
2006โ‚น255.249.96%
2005โ‚น232.1110.39%
2004โ‚น210.2716.35%
2003โ‚น180.7226.73%
2002โ‚น142.6190.29%
2001โ‚น74.9453.51%
2000โ‚น48.82-22900%
1999-โ‚น0.21-101.11%
1998โ‚น19.27-216.88%
1997-โ‚น16.49

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
โ‚น644.09 11.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น29.22-105.05%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น78.80-113.61%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น80.51-113.91%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น124.55-78.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands